SFBC International to Present at the Lehman Brothers Ninth Annual Global Healthcare Conference on Thursday, March 9, 2006; Webc

SFBC International, Inc. (NASDAQ: SFCC), a provider of
drug development services to branded pharmaceutical, biotechnology,
generic drug and medical device companies, today announced that
Jeffrey P. McMullen, chief executive officer, will present at the
Lehman Brothers Ninth Annual Global Healthcare Conference at 2:30 p.m.
ET on Thursday, March 9, 2006. The conference will take place at The
Loews Miami Beach Hotel in South Beach, FL.
   All interested parties can access a live audio Webcast of the
presentation through the "Webcasts" section of SFBC's Web site at
www.sfbci.com. The replay of the Webcast will be available within 48
hours of the live presentation and will remain available for 90 days
following the conference.

   About SFBC International, Inc.

   SFBC International, Inc. provides early through late stage
clinical drug development services to branded pharmaceutical,
biotechnology, generic drug and medical device companies around the
world. SFBC has more than 30 offices located in North America, Europe
(including Central and Eastern Europe), South America, Asia, and
Australia. In early clinical development services, SFBC specializes
primarily in the areas of Phase I and early Phase II clinical trials
and bioanalytical laboratory services, including early clinical
pharmacology. SFBC also provides late stage clinical development
services globally that focus on Phase II through IV clinical trials.
SFBC also offers a range of complementary services, including data
management and biostatistics, medical and scientific affairs,
regulatory affairs and submissions, and clinical IT solutions.
Additional information is available on SFBC's website at
http://www.sfbci.com.